Study: 27 Percent of CBD Products Would Fail Legal Weed’s Dosage Testing

  • Researchers found that about 27 percent of products had variances in claims versus potency that wouldn’t pass the standard for products sold in state-legal marijuana industries.
  • According to LeafReport, 10 percent is considered the maximum cannabinoid variance in the marijuana industry, and 27 of the 37 products tested (73 percent) fell within that margin of error.
  • We thought we would see a lot of products that have a larger variance than 10 percent, which is the acceptable variance,” Gans explains.

Read full article: